Pine Valley Investments’s Lineage Cell Therapeutics LCTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-18,000
Closed -$16.3K 498
2024
Q3
$16.3K Hold
18,000
﹤0.01% 468
2024
Q2
$18K Hold
18,000
﹤0.01% 444
2024
Q1
$26.6K Buy
+18,000
New +$26.6K ﹤0.01% 444